CD4 and infection: On the other hand, the fact that 91% of coinfected patients were receiving antiretroviral therapy suggests that, although access to treatment is adequate, these individuals remain susceptible to mpox infection, raising questions about the impact of relative immunosuppression due to higher viral loads and lower CD4 counts on the clinical course of the disease [50].